SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings
 

About: Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 68

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™